[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369683-105":59,"doc-detail-369683-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cholesterol-to-lymphocyte-ratio-clr-based-nomogram-as-a-prognostic-tool-in-nasopharyngeal-carcinoma-a-large-scale-long-term-retrospective-study","Cholesterol-to-lymphocyte ratio (CLR)-based nomogram as a prognostic tool in nasopharyngeal carcinoma - a large-scale long-term retrospective study","","Cholesterol-to-lymphocyte ratio (CLR) is evaluated as a prognostic biomarker for nasopharyngeal carcinoma (NPC) in patients treated with platinum-based concurrent chemoradiotherapy. A retrospective cohort of 842 individuals undergoes univariate and multivariate analyses to identify independent predictors. CLR-based nomograms are built to improve survival prediction, and their discriminative performance is compared with traditional AJCC/UICC staging using concordance indices. Low CLR is associated with better OS and PFS.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cholesterol-to-lymphocyte-ratio-clr-based-nomogram-as-a-prognostic-tool-in-nasopharyngeal-carcinoma-a-large-scale-long-term-retrospective-study/369683/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cholesterol-to-lymphocyte-ratio-clr-based-nomogram-as-a-prognostic-tool-in-nasopharyngeal-carcinoma-a-large-scale-long-term-retrospective-study/369683.png","ImageObject",300,407,{"name":92,"@type":93},"Cart","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What biomarker was investigated for prognostic prediction in NPC?","Question",{"text":113,"@type":114},"The study investigated the cholesterol-to-lymphocyte ratio (CLR) as a potential prognostic factor.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the study designed and who were included?",{"text":118,"@type":114},"It was a retrospective analysis of 842 NPC patients who received platinum-based concurrent chemoradiotherapy.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the results show about low CLR and survival outcomes?",{"text":122,"@type":114},"Low CLR (≤ 3.06) was significantly associated with improved overall survival and progression-free survival, and CLR showed independent prognostic value in multivariate assessment for OS.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369683,1790218994,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},18829141979164,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Yuan et al. European Journal  \nEuropean Journal of Medical Research (2025) 30:644  \n[https://doi.org/10.1186/s40001-025-02793-z](https://doi.org/10.1186/s40001-025-02793-z of Medical Research)[ of Medical Research](https://doi.org/10.1186/s40001-025-02793-z of Medical Research)  \n RESEARCH Open Access  \nCholesterol-to-lymphocyte ratio  \n(CLR)-based nomogram as a prognostic tool in nasopharyngeal carcinoma: a large-scale long-term retrospective study  \nJing Yuan1†, Wei‑Qiong Ni2†, Yong‑Miao Lin 1†, Ao‑Qiang Chen1, Zhi‑Qing Long 1, Si‑Fen Wang1, Fang‑Fang Duan 1, Chao Zhang1, Xin Huang1, Xue‑Wen Zhang1, Xin‑Yu Liu 1, Wen Xia1, De‑Huan Xie3, Yu‑Ling Zhang4†, Sha‑Sha Du3† and Xin Hua3*†  \nAbstract  \nBackground Nasopharyngeal carcinoma (NPC) is a prevalent malignancy characterized by variable outcomes, even after standardized treatment protocols. The American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system has proven limited in its ability to predict survival, which highlights the neces‑ sity for the discovery of new biomarkers.  \nMethods This study was a retrospective analysis of 842 NPC patients who received platinum‑based concurrent chemoradiotherapy (CCRT) . The cholesterol‑to‑lymphocyte ratio (CLR) was calculated and evaluated as a potential prognostic factor. Both univariate and multivariate analyses were conducted to pinpoint independent prognostic vari‑ ables. Furthermore, CLR‑based nomograms were developed and assessed for its predictive accuracy.  \nResults Low CLR (≤ 3 . 06) was significantly linked to both improved overall survival (OS; HR = 0 . 640, 95% CI 0.473– 0. 866, P \u003C 0. 001)and progression‑free survival (PFS; HR = 0 . 754, 95% CI 0.586–0. 970, P = 0 . 028) . Multivariate analysis confirmed CLR as an independent prognostic factor for OS (but only in univariate analysis for PFS) . Additionally, age, tumor stage, nodal stage, and body mass index were independently associated with both OS and PFS in multivariate analysis. The CLR‑based nomogram showed superior discriminative performance compared to the traditional staging system, with higher C‑indices for both OS(0 . 668 vs 0 . 635) and PFS (0 . 655 vs 0 . 625) .  \nConclusions CLR stands as an independent prognostic factor for NPC patients undergoing CCRT. The CLR‑based nomogram (incorporating five independent prognostic factors: age, T stage, N stage, BMI, and CLR) provides a tailored approach to predicting survival, enabling healthcare providers to adjust treatment strategies in accordance with indi‑ vidual risk profiles. Further validation of these findings in external cohorts is necessary, as well as exploration of CLR’s clinical utility in directing treatment decisions.  \n\n| †Jing Yuan, Wei‑Qiong Ni, and Yong‑Miao Lin have contributed equally to this article as first authors. |\n| --- |\n| †Yu‑Ling Zhang, Sha‑Sha Du, and Xin Hua have contributed equally to this work as senior authors. |\n\n*Correspondence: Xin Hua [huaxin@gdph.org.cn](huaxin@gdph.org.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution‑NonCommercial‑NoDerivatives 4.0 International License, which permits any non‑commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain ","cbCaiaq9j0hAMaFn","https://ap.wps.com/l/cbCaiaq9j0hAMaFn","pdf",2094214,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What biomarker was investigated for prognostic prediction in NPC?\",\"answer\":\"The study investigated the cholesterol-to-lymphocyte ratio (CLR) as a potential prognostic factor.\"},{\"question\":\"How was the study designed and who were included?\",\"answer\":\"It was a retrospective analysis of 842 NPC patients who received platinum-based concurrent chemoradiotherapy.\"},{\"question\":\"What did the results show about low CLR and survival outcomes?\",\"answer\":\"Low CLR (≤ 3.06) was significantly associated with improved overall survival and progression-free survival, and CLR showed independent prognostic value in multivariate assessment for OS.\"}]","Cholesterol-to-lymphocyte ratio (CLR)-based nomogram as a prognostic tool in nasopharyngeal carcinoma - a large-scale long-term retrospective study | PDF",1790184099,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/738c5e450d2674f7b90225c9911cb5c8.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/494d9b456a3cfe2d5187c81d42958ac7.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87f09b763827a0d9c71b0efc1fff96bd.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7656b8754e03cc875a659fa5b3300b88.webp",980,1301]